Industry

DisperSol Appoints Tim Scott New President and CEO; Company Changes Name to AustinPx™, Pharmaceutics and Manufacturing

AUSTIN, Texas–(BUSINESS WIRE)–DisperSol Technologies, LLC, a specialty pharmaceutical company, today announced the appointment of Tim Scott as president and chief executive officer (CEO) of the company. At the same time, the company announced that it is changing its name to AustinPx™, Pharmaceutics and Manufacturing, to better reflect the company’s new direction as a contract development … [Read more…]

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine

Data support request for Emergency Use Authorization of a 30-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older Companies have rapidly scaled production and stand ready to deliver doses of Omicron BA.4/BA.5-adapted bivalent vaccines for September, and will begin shipping immediately pending authorization Rolling submission for … [Read more…]

Global Breast Cancer Liquid Biopsy Market to Grow by $464.12 Million Through 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Breast Cancer Liquid Biopsy Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The breast cancer liquid biopsy market is poised to grow by $464.12 mn during 2022-2026, accelerating at a CAGR of 16.35% during the forecast period. The report on the breast cancer liquid biopsy market provides a holistic analysis, market … [Read more…]

Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure

Indonesia National Agency for Drug and Food Control, BPOM, Approved QDENGA (TAK-003) for Use in Individuals Six Years to 45 Years of Age1 QDENGA is the Only Dengue Vaccine Approved in Indonesia for Use in Individuals Without Need for Pre-vaccination Testing Indonesia Approval Marks the First for QDENGA, Takeda’s First Marketed Vaccine Outside of Japan … [Read more…]

Insights on the Neonatal Intensive Care Respiratory Devices Global Market to 2027 – Featuring 3B Medical, AVI Healthcare and Medtronic Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Neonatal Intensive Care Respiratory Devices Market Research Report by Device Type, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Neonatal Intensive Care Respiratory Devices Market size was estimated at USD 1,686.97 million in 2021, USD 1,910.92 million in 2022, and … [Read more…]

North America Pharmaceutical Analytical Testing Outsourcing Market to Surpass $6 Billion by 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End User, Organization Size, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The North American pharmaceutical analytical testing outsourcing market is projected to grow by 7.5% annually in the forecast period and reach $ … [Read more…]

Thermedical Announces FDA Approval of Clinical Trial for SERF Ablation to Treat Patients with Ventricular Tachycardia, Leading Cause of Sudden Cardiac Death

WALTHAM, Mass.–(BUSINESS WIRE)–#CardiacAblation—Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional … [Read more…]

Europe Pharmaceutical Analytical Testing Outsourcing Market Report 2022: Increasing Pipelines for Drug Candidates & Rising Demand for Additional Analytical Details on Drugs Driving 8.4% Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Europe Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End User, Organization Size, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The European pharmaceutical analytical testing outsourcing market was valued at $1,919.1 million in 2021 and will grow by 8.4% annually over 2021-2031, driven … [Read more…]

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from a bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate … [Read more…]

Innoviva Completes Acquisition of La Jolla Pharmaceutical

BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“La Jolla”) at a price of … [Read more…]